UNIVERSAL HEALTH SERVICES-B (UHS) Fundamental Analysis & Valuation

NYSE:UHS • US9139031002

Current stock price

184.04 USD
-1.05 (-0.57%)
At close:
184.25 USD
+0.21 (+0.11%)
After Hours:

This UHS fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

7

1. UHS Profitability Analysis

1.1 Basic Checks

  • In the past year UHS was profitable.
  • In the past year UHS had a positive cash flow from operations.
  • In the past 5 years UHS has always been profitable.
  • Each year in the past 5 years UHS had a positive operating cash flow.
UHS Yearly Net Income VS EBIT VS OCF VS FCFUHS Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B 2B

1.2 Ratios

  • Looking at the Return On Assets, with a value of 9.59%, UHS belongs to the top of the industry, outperforming 93.00% of the companies in the same industry.
  • The Return On Equity of UHS (20.46%) is better than 89.00% of its industry peers.
  • UHS's Return On Invested Capital of 12.52% is amongst the best of the industry. UHS outperforms 87.00% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for UHS is in line with the industry average of 8.85%.
  • The last Return On Invested Capital (12.52%) for UHS is above the 3 year average (10.23%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROIC 12.52%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
UHS Yearly ROA, ROE, ROICUHS Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5 10 15 20

1.3 Margins

  • With an excellent Profit Margin value of 8.57%, UHS belongs to the best of the industry, outperforming 90.00% of the companies in the same industry.
  • In the last couple of years the Profit Margin of UHS has remained more or less at the same level.
  • UHS's Operating Margin of 11.48% is amongst the best of the industry. UHS outperforms 82.00% of its industry peers.
  • UHS's Operating Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 11.48%
PM (TTM) 8.57%
GM N/A
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
UHS Yearly Profit, Operating, Gross MarginsUHS Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2 4 6 8 10

5

2. UHS Health Analysis

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), UHS is creating some value.
  • UHS has less shares outstanding than it did 1 year ago.
  • UHS has less shares outstanding than it did 5 years ago.
  • Compared to 1 year ago, UHS has an improved debt to assets ratio.
UHS Yearly Shares OutstandingUHS Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 20M 40M 60M 80M
UHS Yearly Total Debt VS Total AssetsUHS Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 5B 10B 15B

2.2 Solvency

  • An Altman-Z score of 3.03 indicates that UHS is not in any danger for bankruptcy at the moment.
  • UHS has a Altman-Z score of 3.03. This is in the better half of the industry: UHS outperforms 67.00% of its industry peers.
  • The Debt to FCF ratio of UHS is 5.60, which is a neutral value as it means it would take UHS, 5.60 years of fcf income to pay off all of its debts.
  • UHS has a Debt to FCF ratio (5.60) which is in line with its industry peers.
  • A Debt/Equity ratio of 0.55 indicates that UHS is somewhat dependend on debt financing.
  • The Debt to Equity ratio of UHS (0.55) is better than 61.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Altman-Z 3.03
ROIC/WACC1.6
WACC7.84%
UHS Yearly LT Debt VS Equity VS FCFUHS Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

2.3 Liquidity

  • UHS has a Current Ratio of 1.05. This is a normal value and indicates that UHS is financially healthy and should not expect problems in meeting its short term obligations.
  • UHS has a Current ratio of 1.05. This is in the lower half of the industry: UHS underperforms 67.00% of its industry peers.
  • A Quick Ratio of 0.98 indicates that UHS may have some problems paying its short term obligations.
  • UHS has a worse Quick ratio (0.98) than 67.00% of its industry peers.
Industry RankSector Rank
Current Ratio 1.05
Quick Ratio 0.98
UHS Yearly Current Assets VS Current LiabilitesUHS Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1B 2B 3B

5

3. UHS Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 30.77% over the past year.
  • The Earnings Per Share has been growing by 14.35% on average over the past years. This is quite good.
  • The Revenue has grown by 9.71% in the past year. This is quite good.
  • The Revenue has been growing by 8.48% on average over the past years. This is quite good.
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%

3.2 Future

  • Based on estimates for the next years, UHS will show a small growth in Earnings Per Share. The EPS will grow by 7.50% on average per year.
  • UHS is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 4.27% yearly.
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UHS Yearly Revenue VS EstimatesUHS Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5B 10B 15B 20B
UHS Yearly EPS VS EstimatesUHS Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 5 10 15 20 25

8

4. UHS Valuation Analysis

4.1 Price/Earnings Ratio

  • With a Price/Earnings ratio of 8.46, the valuation of UHS can be described as very reasonable.
  • 96.00% of the companies in the same industry are more expensive than UHS, based on the Price/Earnings ratio.
  • The average S&P500 Price/Earnings ratio is at 24.88. UHS is valued rather cheaply when compared to this.
  • UHS is valuated cheaply with a Price/Forward Earnings ratio of 7.71.
  • Compared to the rest of the industry, the Price/Forward Earnings ratio of UHS indicates a rather cheap valuation: UHS is cheaper than 95.00% of the companies listed in the same industry.
  • UHS is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 8.46
Fwd PE 7.71
UHS Price Earnings VS Forward Price EarningsUHS Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, UHS is valued cheaper than 89.00% of the companies in the same industry.
  • UHS's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. UHS is cheaper than 75.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 13.24
EV/EBITDA 6.09
UHS Per share dataUHS EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150 200 250

4.3 Compensation for Growth

  • UHS's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • UHS has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)0.88
PEG (5Y)0.59
EPS Next 2Y9.29%
EPS Next 3Y9.15%

5

5. UHS Dividend Analysis

5.1 Amount

  • With a yearly dividend of 0.43%, UHS is not a good candidate for dividend investing.
  • Compared to an average industry Dividend Yield of 0.50, UHS pays a bit more dividend than its industry peers.
  • With a Dividend Yield of 0.43, UHS pays less dividend than the S&P500 average, which is at 1.90.
Industry RankSector Rank
Dividend Yield 0.43%

5.2 History

  • On average, the dividend of UHS grows each year by 32.23%, which is quite nice.
  • UHS has been paying a dividend for at least 10 years, so it has a reliable track record.
  • UHS has not decreased its dividend in the last 3 years.
Dividend Growth(5Y)32.23%
Div Incr Years0
Div Non Decr Years4
UHS Yearly Dividends per shareUHS Yearly Dividends per shareYearly Dividends per share 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0.2 0.4 0.6

5.3 Sustainability

  • UHS pays out 3.44% of its income as dividend. This is a sustainable payout ratio.
  • UHS's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP3.44%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
UHS Yearly Income VS Free CF VS DividendUHS Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 500M 1B 1.5B
UHS Dividend Payout.UHS Dividend Payout, showing the Payout Ratio.UHS Dividend Payout.PayoutRetained Earnings

UHS Fundamentals: All Metrics, Ratios and Statistics

UNIVERSAL HEALTH SERVICES-B

NYSE:UHS (3/27/2026, 8:04:00 PM)

After market: 184.25 +0.21 (+0.11%)

184.04

-1.05 (-0.57%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25
Earnings (Next)04-27
Inst Owners97.33%
Inst Owner Change-1.6%
Ins Owners5.83%
Ins Owner Change7.48%
Market Cap11.24B
Revenue(TTM)17.36B
Net Income(TTM)1.49B
Analysts70.37
Price Target253.23 (37.6%)
Short Float %4%
Short Ratio2.56
Dividend
Industry RankSector Rank
Dividend Yield 0.43%
Yearly Dividend0.81
Dividend Growth(5Y)32.23%
DP3.44%
Div Incr Years0
Div Non Decr Years4
Ex-Date03-02
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)7.59%
Min EPS beat(2)-1.33%
Max EPS beat(2)16.52%
EPS beat(4)3
Avg EPS beat(4)8.24%
Min EPS beat(4)-1.33%
Max EPS beat(4)16.52%
EPS beat(8)7
Avg EPS beat(8)12.07%
EPS beat(12)11
Avg EPS beat(12)9.91%
EPS beat(16)13
Avg EPS beat(16)6.42%
Revenue beat(2)1
Avg Revenue beat(2)0.55%
Min Revenue beat(2)-1.34%
Max Revenue beat(2)2.44%
Revenue beat(4)2
Avg Revenue beat(4)-0.25%
Min Revenue beat(4)-2.29%
Max Revenue beat(4)2.44%
Revenue beat(8)6
Avg Revenue beat(8)0.26%
Revenue beat(12)8
Avg Revenue beat(12)0.15%
Revenue beat(16)12
Avg Revenue beat(16)0.29%
PT rev (1m)0%
PT rev (3m)-0.28%
EPS NQ rev (1m)1.65%
EPS NQ rev (3m)1.75%
EPS NY rev (1m)0.43%
EPS NY rev (3m)-0.14%
Revenue NQ rev (1m)1.39%
Revenue NQ rev (3m)1.37%
Revenue NY rev (1m)1.49%
Revenue NY rev (3m)1.49%
Valuation
Industry RankSector Rank
PE 8.46
Fwd PE 7.71
P/S 0.65
P/FCF 13.24
P/OCF 6.03
P/B 1.55
P/tB 3.42
EV/EBITDA 6.09
EPS(TTM)21.76
EY11.82%
EPS(NY)23.86
Fwd EY12.96%
FCF(TTM)13.9
FCFY7.55%
OCF(TTM)30.52
OCFY16.58%
SpS284.25
BVpS119.1
TBVpS53.78
PEG (NY)0.88
PEG (5Y)0.59
Graham Number241.48
Profitability
Industry RankSector Rank
ROA 9.59%
ROE 20.46%
ROCE 16.23%
ROIC 12.52%
ROICexc 12.66%
ROICexgc 18.85%
OM 11.48%
PM (TTM) 8.57%
GM N/A
FCFM 4.89%
ROA(3y)7.54%
ROA(5y)7.04%
ROE(3y)16.42%
ROE(5y)15.38%
ROIC(3y)10.23%
ROIC(5y)9.37%
ROICexc(3y)10.34%
ROICexc(5y)9.46%
ROICexgc(3y)15.38%
ROICexgc(5y)14.27%
ROCE(3y)13.26%
ROCE(5y)12.14%
ROICexgc growth 3Y22.6%
ROICexgc growth 5Y1.17%
ROICexc growth 3Y23.35%
ROICexc growth 5Y3.38%
OM growth 3Y15.31%
OM growth 5Y-0.46%
PM growth 3Y19.4%
PM growth 5Y1.04%
GM growth 3YN/A
GM growth 5YN/A
F-Score8
Asset Turnover1.12
Health
Industry RankSector Rank
Debt/Equity 0.55
Debt/FCF 5.6
Debt/EBITDA 1.53
Cap/Depr 164.07%
Cap/Sales 5.85%
Interest Coverage 12.78
Cash Conversion 71.36%
Profit Quality 57.04%
Current Ratio 1.05
Quick Ratio 0.98
Altman-Z 3.03
F-Score8
WACC7.84%
ROIC/WACC1.6
Cap/Depr(3y)152.09%
Cap/Depr(5y)148.58%
Cap/Sales(3y)5.67%
Cap/Sales(5y)5.85%
Profit Quality(3y)76.18%
Profit Quality(5y)54.04%
High Growth Momentum
Growth
EPS 1Y (TTM)30.77%
EPS 3Y29.98%
EPS 5Y14.35%
EPS Q2Q%19.51%
EPS Next Y9.63%
EPS Next 2Y9.29%
EPS Next 3Y9.15%
EPS Next 5Y7.5%
Revenue 1Y (TTM)9.71%
Revenue growth 3Y9.03%
Revenue growth 5Y8.48%
Sales Q2Q%9.05%
Revenue Next Year6.52%
Revenue Next 2Y5.74%
Revenue Next 3Y5.62%
Revenue Next 5Y4.27%
EBIT growth 1Y18.56%
EBIT growth 3Y25.72%
EBIT growth 5Y7.99%
EBIT Next Year34.17%
EBIT Next 3Y13.52%
EBIT Next 5YN/A
FCF growth 1Y-24.4%
FCF growth 3Y47.99%
FCF growth 5Y-12.18%
OCF growth 1Y-9.81%
OCF growth 3Y23.24%
OCF growth 5Y-4.61%

UNIVERSAL HEALTH SERVICES-B / UHS Fundamental Analysis FAQ

What is the fundamental rating for UHS stock?

ChartMill assigns a fundamental rating of 6 / 10 to UHS.


Can you provide the valuation status for UNIVERSAL HEALTH SERVICES-B?

ChartMill assigns a valuation rating of 8 / 10 to UNIVERSAL HEALTH SERVICES-B (UHS). This can be considered as Undervalued.


What is the profitability of UHS stock?

UNIVERSAL HEALTH SERVICES-B (UHS) has a profitability rating of 7 / 10.


What is the financial health of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The financial health rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10.


How sustainable is the dividend of UNIVERSAL HEALTH SERVICES-B (UHS) stock?

The dividend rating of UNIVERSAL HEALTH SERVICES-B (UHS) is 5 / 10 and the dividend payout ratio is 3.44%.